AMDL Trading Analysis - 10/20/2026 01:46 PM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge context for AMDL (Applied Molecular Technologies / similarly-ticketed micro-cap biotech names) suggests the following thematic headlines that may relate to the tape:

• AMDL highlighted in late-September trading forums after a volatile run from sub-$12 to over $80 on speculative catalyst chatter.
• Company noted to be pre-revenue with no published EPS, keeping it dependent on financing or partnership news.
• Biotech micro-cap sector saw broad volatility in October as risk-off flows hit low-cap names with high historical volatility.
• No confirmed FDA or clinical-readout date has been announced; any move remains sentiment- and flow-driven.
• Options-market activity surged in October, consistent with a retail-driven name lacking fundamental support.

Context: The headlines above are separate from the embedded data. They help explain why AMDL shows a 111.40% historical volatility and a wide 30-day range of $49.68 to $91.16, but the analysis below is strictly data-driven.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for AMDL:

• Trailing EPS: null; Forward EPS: null; Revenue: null; Revenue growth: null — no profitability or top-line data available.
• Profit margins (gross/operating/net): all null; Return on Equity: null; Debt/Equity: null; Free Cash Flow: null.
• Trailing P/E: null; Forward P/E: null; PEG ratio: null — valuation cannot be computed from earnings.
• Market cap: $1,041,205,000.00; Shares out: 17,210,000.00; Dividend yield: 0.00%.
• Institutional ownership: 40.50%; Average volume: 1,972,000.00; 52-week range: $10.80 to $91.16.
• Historical volatility: 111.40%; Beta: null; Analyst target mean: null; Recommendation key: null.

Fundamental picture is absent of earnings/margin data, indicating a pre-revenue or non-reporting issuer. This diverges from the bullish options sentiment and aligns with weak technicals (price below all major SMAs).

Current Market Position

Current price per indicators: $60.63 (as of 2026-10-19 close). Minute bars show 2026-10-20 13:15 close at $60.45, up from $60.20 at 12:55, a slight intraday uptick.

Daily history: 2026-10-19 open $62.68, high $63.50, low $59.49, close $60.63, volume 2,095,429. Prior session 2026-10-16 closed $57.94, showing a bounce attempt that faded.

Intraday momentum: first 5 minute bars 10-19 show decline from $63.02 to $60.69; last 5 bars 10-20 show slow climb $60.20 to $60.45 on low volume (<18k/bar).

Technical Analysis

Price $60.63 is below SMA 5 ($65.77), SMA 20 ($77.58), and SMA 50 ($63.06) — full bearish alignment, no golden cross. RSI 33.06 shows oversold-but-not-extreme momentum. MACD negative with histogram -0.01 = mild bearish pressure. Bollinger: price below lower band ($61.11) = expanded volatility downside. 30-day range high $91.16, low $49.68; price sits near 23% of range (low zone).

True Sentiment Analysis (Delta 40-60 Options)

Per embedded options sentiment (2026-10-20 13:46):

Call Volume: $690,610.00 (93.00%) Put Volume: $51,820.00 (7.00%) Total: $742,430.00

Sentiment: Bullish (call contracts 570 vs put 72). Pure directional conviction strongly favors calls. This diverges from bearish technicals (price below SMAs, RSI 33, MACD neg). Spread engine noted: "Divergence detected between technical indicators and options sentiment."

Key Price Levels (Observational Only)